Panacea Biotec Share Price

Panacea Biotec Share Price

NSE: PANACEABIO
|
Pharmaceuticals

₹ 357.60

-₹5.60 (-1.54%)
1D
Last updated 07 Oct, 2026, 15:51 IST

Panacea Biotec Share Price Today

As of 8 Oct 2026, Panacea Biotec share price is ₹357.60. The stock opened at ₹361.70, compared to its previous close of ₹363.20. During today's trading session, Panacea Biotec share price moved in the range of ₹355.55 to ₹365.00, with an average price of ₹360.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹292.40 and a high of ₹647.00. On the performance front, Panacea Biotec share price has increased by 11.38% over the last six months and is down 17.17% on a year-on-year basis.

₹355.55
1.54% down today
₹365.00
1D LOW
1D HIGH

Panacea Biotec Returns Calculator

Volume
46,154
Average traded price
₹360.67
Last traded time
03:51:16 07 Oct
Last traded quantity
1
Circuit
L
H
₹286.10
₹429.10
52-week
L
H
₹292.40
₹647.00
Mkt Cap Cr
2,193.39
P/E
-245.27
P/B
2.7
ROA
-0.71%
ROE
-2.93%
ROCE
-2.42%
Quick Ratio
0.92
EV/EBITDA
76.11
Based on fundamentals, this stock's
Step 3 of 5
Performance
Neutral
Panacea Biotec performance is moderate compared to markets
Step 1 of 5
Valuation
Overvalued
Panacea Biotec appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Panacea Biotec revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,32,120.2335.315.1211.19%13.74%17.33%2.3121.97
Divis Laboratories2,53,389.7686.9515.1714.6%15.32%19.56%3.557.56
Torrent Pharmaceuticals1,79,153.2683.121.34.87%25.49%13.85%0.7538.98
Zydus Lifesciences1,15,710.4425.074.258.57%18.59%17.35%0.9115.38
Laurus Labs1,10,980.13101.8320.9510.38%16.77%16.14%0.6854.21
Cipla1,08,497.0232.013.127.92%11.27%14.95%2.518.37
Mankind Pharma1,02,649.9749.846.327.36%11.74%13.13%0.7427.05
Dr. Reddy's Laboratories1,00,925.3731.532.645.48%11.07%12.54%1.3516.0
Aurobindo Pharma97,238.8726.132.566.34%9.25%11.76%1.1512.47
Lupin91,782.6716.534.0914.47%23.76%24.88%1.429.92

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Panacea Biotec

Panacea Biotec Share Price
ISIN
INE922B01023
Sector Market Cap
₹ 2,193.39 Cr

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.

Panacea Biotec Financial Highlights

  • Revenue: Panacea Biotec reported revenue of ₹656.67 crore in FY26 vs ₹579.75 crore in FY25. It showed an increase of 13.27% on a yearly basis.
  • Operating Profit: Panacea Biotec reported an operating loss of ₹7.37 crore in FY26 vs ₹7.95 crore in FY25. It showed an increase of 7.30% on a year-on-year basis.
  • Net Profit: Panacea Biotec reported a net loss of ₹7.16 crore in FY26 vs ₹8.72 crore in FY25. It showed an increase of 17.89% on a yearly basis.

Panacea Biotec Quarterly Result Highlights

  • Panacea Biotec reported revenue of ₹203.81 crore in Jun 2026, compared with ₹169.30 crore in Mar 2026, representing an increase of 20.38% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported an operating profit of ₹3.57 crore in Jun 2026, compared with ₹1.25 crore in Mar 2026, representing an increase of 385.60% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported a profit of ₹2.20 crore in Jun 2026, compared with ₹1.00 crore in Mar 2026, reflecting an increase of 320.00% on a QoQ basis.
  • The earnings per share (EPS) of Panacea Biotec stood at ₹0.88 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.48%
FII
2.31%
Other DII
2.25%
Retail and other
22.96%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.06%
Dec 20251.36%
Mar 20261.60%
Jun 20262.31%
1 day
-1.54%
1 week
-4.70%
1 month
-5.50%
1 year
-17.17%
3 years
+102.15%
5 years
+30.15%
Day
Open / Close
Change %
07 Oct 26
₹361.70 / ₹357.60
-1.54%
06 Oct 26
₹351.10 / ₹363.20
+3.70%
05 Oct 26
₹360.10 / ₹350.25
-2.45%
01 Oct 26
₹362.00 / ₹359.05
-1.90%
Show more

Panacea Biotec Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹639.77₹559.09₹559.17₹459.95
Other Income₹16.90₹20.66₹25.80₹51.66
Total Revenue₹656.67₹579.75₹584.96₹511.61
Total Expenses₹683.54₹623.70₹619.52₹601.47
Profit Before Tax-₹7.37-₹7.95₹1.48₹12.81
Tax-₹0.21₹0.77₹2.98₹46.55
Profit After Tax-₹7.16-₹8.72-₹1.51-₹33.75
EPS - Basic-₹0.88-₹1.37-₹0.19-₹5.43
EPS - Diluted-₹0.88-₹1.37-₹0.19-₹5.43

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.37-₹7.95₹1.48₹12.81
Income before WC changes₹9.16-₹17.82-₹7.28-₹83.06
Change in Assets₹32.89-₹101.58-₹0.85-₹13.27
Change in Liabilities-₹18.92₹93.00₹10.54-₹323.65
Change in WC₹13.98-₹8.58₹9.69-₹336.91
Cash flow from Operations₹16.69-₹27.37-₹0.10-₹422.45
Cash flow from Investing-₹40.50₹64.98₹10.23₹430.33
Cash flow from Financing-₹1.06-₹2.66-₹2.81-₹18.37
Total Cash Flow-₹24.86₹34.95₹7.32-₹10.49
Cash (Start of the year)₹82.13₹47.17₹39.85₹50.35
Cash (End of the year)₹57.31₹82.13₹47.17₹39.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹749.13₹713.27₹755.49₹708.85
Current Assets₹513.05₹576.47₹485.18₹562.32
Total Assets₹1,262.18₹1,289.75₹1,240.67₹1,271.17
Current Liabilities₹348.69₹366.99₹308.83₹329.73
Net Current Asset₹164.36₹209.48₹176.35₹232.59
Non-Current Liabilities₹84.61₹92.14₹93.61₹101.32
Equity Capital₹828.88₹830.62₹838.23₹840.11
Total Equity & Liabilities₹1,262.18₹1,289.75₹1,240.67₹1,271.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹413.49₹309.86₹359.60₹257.07
Other Income₹18.00₹16.62₹24.91₹34.44
Total Revenue₹431.50₹326.47₹384.51₹291.50
Total Expenses₹475.37₹352.53₹380.31₹354.25
Profit Before Tax-₹43.88-₹26.06₹4.21-₹62.75
Tax-₹13.97-₹10.83₹0.66₹24.79
Profit After Tax-₹29.91-₹15.23₹3.55-₹87.54
EPS - Basic-₹4.88-₹2.49₹0.58-₹14.29
EPS - Diluted-₹4.88-₹2.49₹0.58-₹14.29

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹43.88-₹26.06₹4.21-₹62.75
Income before WC changes-₹1.88₹3.87₹30.95-₹52.32
Change in Assets-₹6.73-₹50.40₹0.78₹5.19
Change in Liabilities-₹27.26₹51.58₹3.22₹37.48
Change in WC-₹33.99₹1.18₹4.00₹42.67
Cash flow from Operations-₹40.17₹3.94₹33.07-₹10.74
Cash flow from Investing-₹18.53-₹60.60-₹46.80₹2.41
Cash flow from Financing₹22.54₹90.07₹12.82₹9.01
Total Cash Flow-₹36.16₹33.41-₹0.91₹0.67
Cash (Start of the year)₹38.50₹5.09₹6.01₹5.33
Cash (End of the year)₹2.42₹38.50₹5.09₹6.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹567.91₹544.44₹570.30₹524.77
Current Assets₹284.49₹325.02₹183.49₹199.13
Total Assets₹852.40₹869.47₹753.79₹723.90
Current Liabilities₹285.21₹351.40₹249.14₹250.85
Net Current Asset-₹0.72-₹26.38-₹65.65-₹51.72
Non-Current Liabilities₹281.98₹204.10₹175.51₹147.40
Equity Capital₹285.21₹313.97₹329.14₹325.65
Total Equity & Liabilities₹852.40₹869.47₹753.79₹723.90
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
357.6
39
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 39
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.05
Neutral
ATR (14)
13.72
Neutral
STOCH(9,6)
27.89
Neutral
STOCH RSI (14)
52.85
Neutral
ADX(9)
21.62
Bearish
UO(9)
44.59
Neutral
ROC(12)
-2.8
Bearish
WillR(14)
-78.59
Neutral
Period
Simple value
Exponential vaue
5D
359.22
360.55
10D
366.69
365.03
20D
374.02
372.95
50D
392.38
397.06
100D
447.47
411.49
Volume trend — traded volume by day
7 Oct0L
6 Oct0L
5 Oct0L
1 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Panacea Biotec Share Price
Panacea Biotec
Pharmaceuticals
Add Stock
Add Another

Panacea Biotec Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.